MSH2 and malignant colon neoplasm: However, inhibiting iNOS activity or genetically ablating iNOS did not alter CRC development in APCMin/+Msh2−/− mice indicating that nitric oxide does not significantly contribute to colon cancer etiology in this mouse model.